MEMORANDUM OPINION
Pending before the Court is defendant’s Motion to Dismiss, or in the alternative, to Transfer to the Western District of Michigan. The plaintiff, Gary Savage (“Savage”), filed a complaint alleging that defendant BioPort Corporation (“BioPort”) is liable for negligence, breach of warranties, and strict products liability related to a product called anthrax vaccine absorbed
I. BACKGROUND
Plaintiff Savage is a citizen of the District of Columbia. (Pl.’s Br. 2.) Defendant BioPort is a corporation with its principal place of business in Lansing, Michigan. (Def. Br. 2 ¶ 1.) Beginning in March 2000, BioPort’s sole business was the manufacture and sale of AVA and certain research and development activities. (Id. at 2 ¶ 5.) In 2002, Savage was stationed as a sergeant in the U.S. Army at Fort Benning, Georgia. (Id. at 1.) In November and December of that year, Savage received three shots of AVA. (Pl.’s Comp. ¶ 66.) On January 4, 2003, Savage was hospitalized after he collapsed while jogging. (Id. at ¶ 67.) Approximately one week later, Savage was transferred from Fort Benning to Walter Reed Army Medical Center in Washington, D.C. (Id. at ¶ 68.) Savage alleges that he suffers serious ailments from the AVA inoculations. (Id. at ¶ 68.)
BioPort is not registered to do business in the District of Columbia. (Def. Br. p. 2 ¶2.) It has never maintained an office, employee, telephone, business records, mailing address, or a registered agent for the service of process in Washington, D.C. (Id.) Furthermore, BioPort does not own or lease real property in the District of Columbia. (Id.) BioPort’s other contacts in the District include: (1) sales contracts with the U.S. Department of Health and Human Services (“HHS”) for the purchase of AVA (Def.’s Reply Br. 3); (2) funding provided to the Partnership for Anthrax Vaccine Education at George Washington University Medical Center (Def.Br-¶ 12); (3) one marketing meeting in the District of Columbia with the District’s Police, Fire, and Emergency Medical Services Chiefs (Id. ¶ 10); (4) advertisements published in Roll Call, The Hill, and The Washington Times newspapers (Id. ¶ 11); (5) contracts with the U.S. Department of Defense (“DoD”) for the sale of AVA (Def.Br.6); (6) shipments of AVA to DoD facilities in the District, made at DoD’s request, amounting to less than one percent of all DoD purchases (Id. ¶ 7); and (7) legal counsel hired in the District to represent BioPort (Id. ¶ 13).
II. DISCUSSION
A. Personal Jurisdiction
BioPort’s Motion to Dismiss states that this Court lacks personal jurisdiction, pursuant to Rule 12(b)(2) of the Federal Rules of Civil Procedure. To determine whether a court has jurisdiction over a defendant, it must first “determine whether jurisdiction over a party is proper under the applicable local long-arm statute and whether it accords with the demands of due process.”
United States v. Ferrara,
1. General Jurisdiction
District of Columbia courts may “exercise ‘general jurisdiction’ over a foreign corporation as to claims not arising from the corporation’s conduct in the District, if the corporation is ‘doing business’ in the District.”
Gorman v. Ameritrade Holding Corp.,
BioPort’s contacts with the District are not sufficiently continuous and systematic to satisfy the due process requirements of general jurisdiction. As previously noted, BioPort does not maintain an office, mailing address, telephone, employee, or registered agent for service of process in the District of Columbia. (Def.’s Br. 7.) BioPort does not own or lease real property or maintain business records in the District.
(Id.)
Furthermore, BioPort has never marketed or sold AVA for distribution or use by the general public, and it has never sold AVA to a resident of the District of Columbia.
(Id.)
BioPort’s contacts are sporadic and insufficient to provide it notice that BioPort must defend itself in the District of Columbia for any claim arising outside of the District.
See Atlantigas,
Savage maintains that BioPort is subject to general jurisdiction under the District’s long-arm statute that reaches “foreign corporations doing business in the district.” D.C.Code 13-334(a); (Pl.’s Br. 6-7, 9.) Savage asserts that BioPort’s contacts in the District satisfy the “doing business” requirement of the long-arm statute. (PL’s Br. 9.) However, the D.C. Circuit distinguishes between “ ‘doing business’ when that term signals local activity sufficient to support all-purpose (general) jurisdiction over a defendant; [and] ‘transacting business,’ invoked as a basis for specific adjudicatory authority over claims relating to the very business transacted.... ”
Crane v. Carr,
2. Specific Jurisdiction
A court’s jurisdiction over a defendant satisfies the demands of due process when there are “certain minimum contacts with [the forum] such that the maintenance of the suit does not offend ‘traditional notions of fair play and substantial justice.’ ”
Int’l Shoe,
(a) A District of Columbia court may exercise personal jurisdiction over a person, who acts directly or by an agent, as to a claim for relief arising from the person’s—
(1) transacting any business in the District of Columbia;....
(b) When jurisdiction over a person is based solely upon this section, only a claim for relief arising from acts enumerated in this section may be asserted against him.
D.C.Code § 13-423 (2006). The
transacting any business
finger of the long-arm statute “has been held by the District of Columbia Court of Appeals to be coextensive [ ] with the Constitution’s due process limit.”
Crane,
Savage relies on
Shoppers Food Warehouse v. Moreno,
BioPort’s contacts with the District through its newspaper advertisements are distinguishable from those in Shoppers. BioPort’s advertisements did not solicit the residents of the District of Columbia to purchase AVA or otherwise transact business with BioPort. All of BioPort’s advertisements emphasized the United States government’s limited allocation of anthrax vaccines to first responders. None of the advertisements offered to sell or provided a means within which to purchase AVA from BioPort. Neither Savage nor any other resident of the District of Columbia transacted business with BioPort to obtain AVA for personal use.
In addition, BioPort’s advertisements were published over a year
after
the injury to Savage occurred. (Def.’s Reply Br. Ex. C). In
Shoppers,
the advertisements di
There is no discernible relationship between BioPort’s advertisements and Savage’s injury. The advertisements were not purposefully directed at any class of customers that Savage might belong to, and the advertisements did not solicit business from District residents. (Def.’s Reply Br. Ex. C.) The advertisements stress the susceptibility of first responders to an anthrax attack and are directed at government officials. The advertisements do not provide any means to purchase AVA, and BioPort does not sell its products to the public. For these reasons, BioPort could not have reasonably anticipated being haled into court to defend against a personal injury suit brought by a District resident.
Savage highlights BioPort’s contacts in the District and their connection to AVA; however, he offers no explanation as to how any of these contacts relate to or give rise to his claim against BioPort. The fact that nearly all of Bio-Port’s contacts within the District are in some way related to AVA or anthrax is not surprising because the manufacture and sale of AVA is BioPort’s sole means of business. Savage’s claim arises from inoculations of AVA received while on active duty with the U.S. Army in Fort Benning, Georgia. (Pl.’s Br. 1.) There is no diseernable relationship between Savage’s claim and BioPort’s contacts with HHS, George Washington University Medical Center, District of Columbia first responders, or BioPort’s legal counsel. Savage has not made any assertions as to the relation between his claim and any of these contacts. Specific jurisdiction requires that a claim “arise out of’ or “be related to” the minimum contacts with the forum state. “[The Court] cannot simply aggregate all of a defendant’s contacts with a state — no matter how dissimilar in terms of geography, time, or substance — as evidence of the constitutionally required minimum contacts.”
RAR, Inc. v. Turner Diesel,
3. Department of Defense Contacts
The only contact that might give rise to Savage’s claims are BioPort’s contracts with DoD, which presumably supplied the AVA administered to Savage at Fort Benning. However, the Court does not find this contact to be sufficient to establish jurisdiction over BioPort. First, BioPort’s contract negotiations occurred outside the District of Columbia with DoD contracting agents in Fort Detrick, Maryland and Falls Church, Virginia. (Def.’s Br. ¶ 14.) This is not sufficient to support jurisdiction under the transacting business finger of the District’s long-arm statute.
See Freiman v. Lazur,
Second, the government contacts principle excludes BioPort’s contacts with DoD from the jurisdictional calculus. “The government contacts principle establishes that entry into the District by nonresidents for the purpose of contacting federal governmental agencies cannot serve as a basis for personal jurisdiction.”
Id.
at 24 (citing
Envtl. Research Int’l, Inc. v. Lockwood Greene Eng’rs, Inc.,
Finally, even if this Court were to find that these contacts constituted “transacting any business,” D.C.Code § 13-423(a)(1), within the District of Columbia, Savage has not shown that his “claim for relief arisfes]” from these alleged contacts. Id. § 13-423(b). Savage has not brought a breach of contract claim, nor is he a party to the contracts between BioPort and DoD. The contracts are not the alleged source of Savage’s injury; instead he maintains that the harm was a result of wrongdoing by BioPort in the production of AVA, which was performed in Michigan. BioPort’s contacts with DoD do not satisfy the District’s long-arm statute requirements; therefore, BioPort is not subject to personal jurisdiction in the District of Columbia.
B. Jurisdictional Discovery
Additional discovery of Bio-Port’s contacts will not affect the jurisdictional outcome. None of the contacts relate to or arise out of Savage’s claim, nor could they conceivably lead any court to believe that general jurisdiction exists. “A district court has broad discretion in its resolution of discovery problems that arise in cases pending before it.”
Hussain v. Nicholson,
Savage relies on
El-Fadl v. Central Bank of Jordan,
III. CONCLUSION
For the foregoing reasons, the Court will grant BioPort’s Motion to Transfer [8] pursuant to 28 U.S.C. § 1404(a) to the Western District of Michigan.
An Order consistent with this Opinion will be entered.
ORDER
Upon consideration of defendant Bio-Port Corporation’s motion to transfer this lawsuit to the United States District Court for the Western District of Michigan pursuant to 28 U.S.C. § 1404(a), plaintiffs brief in opposition thereto, defendant’s reply brief, and for the reasons stated in an accompanying memorandum opinion, it is hereby
ORDERED that BioPort’s motion to transfer is granted, and it is further hereby
ORDERED that this lawsuit be transferred by the Clerk of this Court to the United States District Court for the Western District of Michigan.
